⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL91888 | 0.59 | — | — | |
| SCHEMBL22637 | 0.59 | — | — | |
| SCHEMBL1321648 | 0.58 | — | — | |
| Hydrochloric Acid SCHEMBL27923435 | 0.56 | — | — | |
| SCHEMBL14199480 | 0.56 | — | — | |
| SCHEMBL17066397 | 0.56 | — | — | |
| SCHEMBL3348276 | 0.56 | — | — | |
| SCHEMBL1976641 | 0.54 | — | — | |
| Fluoromethane SCHEMBL28140967 | 0.54 | — | — | |
| SCHEMBL121228 | 0.54 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190203213-A1 | Growth Hormones with Prolonged In-Vivo Efficacy | NOVO NORDISK HEALTHCARE AG (CH) | 2019-07-04 | — | — | US | disclosed |
| US-20170239362-A1 | Growth Hormones with Prolonged In-Vivo Efficacy | NOVO NORDISK HEALTHCARE AG (CH) | 2017-08-24 | — | — | US | disclosed |
| EP-3188271-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | Idemitsu Kosan Co., Ltd (JP) | 2017-07-05 | — | — | EP | disclosed |
| US-9675733-B2 | Methods of modulating bone remodeling | TISSUETECH, INC. (US) | 2017-06-13 | — | — | US | disclosed |